Jazz Pharmaceuticals
JAZZ
JAZZ
470 hedge funds and large institutions have $8.3B invested in Jazz Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 58 funds opening new positions, 167 increasing their positions, 154 reducing their positions, and 63 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
470
Holders Change
-14
Holders Change %
-2.89%
% of All Funds
7.52%
Holding in Top 10
5
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-37.5%
% of All Funds
0.08%
New
58
Increased
167
Reduced
154
Closed
63
Calls
$14.8M
Puts
$8.22M
Net Calls
+$6.55M
Net Calls Change
+$36.6M
Top Buyers
| 1 |
Swedbank
Stockholm,
Sweden
|
+$112M |
| 2 |
Millennium Management
New York
|
+$105M |
| 3 |
BG
Baupost Group
Boston,
Massachusetts
|
+$70M |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$47.8M |
| 5 |
LSV Asset Management
Chicago,
Illinois
|
+$38.4M |
Top Sellers
| 1 |
JPMorgan Chase & Co
New York
|
-$106M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$60.6M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$60.6M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$52.1M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$29.2M |
